Phosphodiesterase Type 5 Inhibitors in Patients With Group 2 Pulmonary Hypertension

Conditions: Group 2 Pulmonary Hypertension Interventions: Drug: tadalafil 20 mg then 40 mg if tolerated Sponsors: Beni-Suef University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials